Radhika Kumari, MD
Gastroenterology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 7
- 3 carriers
- Offices
- 6
Offices
6 locations · Central California Faculty Medical Group Inc · Central Valley General Hospital · Adventist Health Physicians Network · Alameda Health System · Permanente Medical Group Inc
Looking this up.
Hospitals listed: Adventist Health Hanford · Community Regional Medical Center · Kaiser Foundation Hospital - San Leandro. That is not proof they admit you there this week.
Plans that list them
7 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kumari’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
7 of 7 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A117307 · Current
Licensed to practise in California · since 2011 · expires 2027-02-28 · University of Health Sciences, Vijayawada, S.V. Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health HanfordHanford, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.277, Oct 2024 – Sep 2025
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
- Kaiser Foundation Hospital - San LeandroSan Leandro, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.316, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Hanford
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.277 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 614 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.38 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 190.5 (130.11 to 250.89) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 101 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 43 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.5 · 269 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.8 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.2 · 145 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 1,486 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,684 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.08 to 0.49) · 3,819 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.67 (0.36 to 4.98) · 613 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.32) · 154 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.65 (1.02 to 4.28) · 598 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.24 (0 to 16.19) · 160 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.85 (0.67 to 9.03) · 147 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 1) · 3,186 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.418 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.574 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 38 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 14.5 · 302 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 22 · 380 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 407 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 113 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10 to 17) · 896 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 228 cases | No different | Jan 2024 – Dec 2024 |
What patients said (947 patients answered, 13% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Kaiser Foundation Hospital - San Leandro
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.316 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0 to 2.11) · 166 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.45 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.3 · 2,150 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 728 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 762 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.32 (0.75 to 5.9) · 106 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.61 (0.89 to 4.33) · 97 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.83 (0 to 18.72) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.11 (0.82 to 9.4) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.09 (0.57 to 3.62) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.51) · 585 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 104 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.37 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.33 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.517 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 501 cases | None | Jul 2023 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.1 · 415 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 102 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.5 · 137 cases | None | Jul 2023 – Jun 2025 |
What patients said (635 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$7,548
Medicare paid this office $7,548 for 96 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 12 | $765 | $64 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 28 | $510 | $18 |
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 26 | More than 54% of doctors who do this |
Who their Medicare patients are
96 Original Medicare patients in 2024. Average age 67 · Under 65 29% · Women 46% · Also on Medicaid 48% · Health risk score 3.18. Sicker patients than 9 in 10 peers; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 39% · Chronic kidney disease 39% · Coronary heart disease 31% · Depression 29% · Heart failure 25% · Cancer 13% · COPD 11%.
The office billed $64,119, Medicare allowed $12,220 and paid $7,548; for 126 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 96 | 126 | 67 | 3.18 | $64,119 | $7,548 |
| 2023 | 373 | 903 | 68 | 3.13 | $440,833 | $71,540 |
| 2022 | 384 | 1,084 | 67 | 2.89 | $612,376 | $100,148 |
| 2021 | 351 | 1,109 | 67 | 2.93 | $761,344 | $115,784 |
| 2020 | 299 | 882 | 67 | 2.85 | $616,301 | $89,727 |
| 2019 | 303 | 722 | 67 | 3.15 | $382,788 | $71,919 |
| 2018 | 281 | 685 | 66 | 3.11 | $304,247 | $62,912 |
| 2017 | 302 | 888 | 65 | 2.98 | $391,668 | $76,458 |
| 2016 | 241 | 631 | 66 | 3.02 | $324,443 | $64,633 |
| 2015 | 290 | 763 | 66 | 3.09 | $406,578 | $81,427 |
| 2014 | 228 | 779 | 65 | 2.89 | $362,741 | $79,028 |
| 2013 | 219 | 440 | 62 | 3.00 | $192,916 | $42,898 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $15,613 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $11,080 | $110 |
| Return visit (30+ min) | 73 | $9,902 | $104 |
| Return visit (30+ min) | 40 | $3,853 | $82 |
| Long return visit (40+ min) | 25 | $3,345 | $119 |
| New patient visit (45+ min) | 25 | $3,262 | $130 |
| Telehealth originating site facility fee | 110 | $2,670 | $20 |
| Short return visit (20+ min) | 35 | $2,420 | $67 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,476 | $105 |
| Long return visit (40+ min) | 12 | $1,216 | $94 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $1,129 | $45 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 19 | $631 | $33 |
| Measurement of liver stiffness | 12 | $97 | $8 |
2022: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 71 | $24,872 | $92 |
| Long return visit (40+ min) | 93 | $20,821 | $150 |
| Long return visit (40+ min) | 55 | $9,153 | $119 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $5,172 | $185 |
| New patient visit (45+ min) | 31 | $4,324 | $139 |
| Telehealth originating site facility fee | 137 | $4,117 | $21 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $3,715 | $64 |
| Return visit (30+ min) | 30 | $3,505 | $110 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $3,427 | $107 |
| New patient visit (60+ min) | 18 | $3,135 | $174 |
| Return visit (30+ min) | 12 | $1,088 | $91 |
| New patient visit (30+ min) | 11 | $976 | $89 |
| Short return visit (20+ min) | 11 | $970 | $88 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 18 | $500 | $28 |
| Measurement of liver stiffness | 22 | $213 | $10 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 17 | $56 | $3 |
2021: 13 services
| Long return visit (40+ min) | 105 | $26,640 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $25,728 | $95 |
| Long return visit (40+ min) | 56 | $14,615 | $128 |
| New patient visit (60+ min) | 38 | $7,617 | $200 |
| Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | 19 | $4,821 | $230 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,441 | $185 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 37 | $4,371 | $109 |
| Telehealth originating site facility fee | 119 | $3,815 | $21 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,390 | $66 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,328 | $212 |
| Return visit (30+ min) | 16 | $1,886 | $99 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,239 | $113 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 17 | $67 | $4 |
2020: 13 services
| Long return visit (40+ min) | 80 | $15,750 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $15,192 | $97 |
| Long return visit (40+ min) | 53 | $10,612 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $9,434 | $189 |
| New patient visit (60+ min) | 40 | $7,595 | $190 |
| Return visit (30+ min) | 23 | $2,448 | $98 |
| Telehealth originating site facility fee | 78 | $2,390 | $21 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,365 | $68 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $2,210 | $110 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,872 | $104 |
| Biopsy of large bowel using a flexible endoscope | 13 | $1,412 | $109 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,167 | $106 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 20 | $94 | $4 |
2019: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $20,225 | $93 |
| Long return visit (40+ min) | 52 | $8,368 | $101 |
| Long return visit (40+ min) | 37 | $6,467 | $95 |
| Return visit (30+ min) | 43 | $3,984 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,918 | $178 |
| New patient visit (60+ min) | 24 | $3,635 | $151 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 30 | $3,047 | $98 |
| Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | 11 | $2,976 | $229 |
| Return visit (30+ min) | 32 | $2,731 | $68 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,428 | $95 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,388 | $99 |
| New patient visit (30+ min) | 13 | $877 | $67 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 20 | $97 | $5 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 14 | $63 | $4 |
2018: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $16,850 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,360 | $182 |
| Return visit (30+ min) | 59 | $5,752 | $66 |
| Long return visit (40+ min) | 36 | $5,088 | $94 |
| Long return visit (40+ min) | 37 | $5,036 | $93 |
| Return visit (30+ min) | 42 | $3,268 | $62 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,893 | $96 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,446 | $204 |
| New patient visit (60+ min) | 15 | $1,997 | $133 |
| New patient visit (45+ min) | 11 | $1,257 | $114 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,086 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,085 | $64 |
| New patient visit (30+ min) | 13 | $908 | $70 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 34 | $178 | $4 |
2017: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $17,574 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $6,608 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,526 | $181 |
| Return visit (30+ min) | 58 | $6,160 | $70 |
| Long return visit (40+ min) | 44 | $6,040 | $92 |
| Return visit (30+ min) | 55 | $5,000 | $65 |
| Long return visit (40+ min) | 32 | $4,293 | $89 |
| Hospital discharge day management, more than 30 minutes | 29 | $3,535 | $98 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 31 | $3,474 | $105 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,510 | $109 |
| New patient visit (30+ min) | 17 | $971 | $57 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 54 | $288 | $5 |
2016: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $20,925 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $9,013 | $180 |
| Long return visit (40+ min) | 41 | $5,473 | $91 |
| Long return visit (40+ min) | 27 | $4,119 | $90 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 29 | $3,026 | $101 |
| New patient visit (60+ min) | 21 | $3,000 | $143 |
| Return visit (30+ min) | 37 | $2,864 | $64 |
| Return visit (30+ min) | 32 | $2,732 | $64 |
| Hospital discharge day management, more than 30 minutes | 21 | $2,042 | $97 |
| New patient visit (60+ min) | 14 | $1,739 | $124 |
2015: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 71 | $22,199 | $92 |
| Long return visit (40+ min) | 88 | $13,843 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $10,679 | $181 |
| New patient visit (60+ min) | 53 | $7,814 | $147 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | $3,556 | $209 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 33 | $3,498 | $103 |
| Return visit (30+ min) | 42 | $3,024 | $62 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,821 | $101 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,788 | $94 |
| New patient visit (30+ min) | 16 | $1,088 | $68 |
| Return visit (30+ min) | 13 | $1,036 | $69 |
| Short return visit (20+ min) | 20 | $911 | $43 |
2014: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 77 | $28,268 | $92 |
| Long return visit (40+ min) | 77 | $14,830 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $9,353 | $180 |
| Return visit (30+ min) | 49 | $4,335 | $70 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 32 | $3,345 | $98 |
| New patient visit (60+ min) | 21 | $3,026 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,025 | $64 |
| Short return visit (20+ min) | 17 | $865 | $43 |
| New patient visit (30+ min) | 11 | $632 | $57 |
2013: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $9,456 | $88 |
| Long return visit (40+ min) | 46 | $6,456 | $95 |
| New patient visit (60+ min) | 31 | $4,486 | $145 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,430 | $170 |
| Long return visit (40+ min) | 35 | $3,121 | $84 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $3,102 | $111 |
| Return visit (30+ min) | 30 | $2,165 | $68 |
| Return visit (30+ min) | 22 | $1,938 | $72 |
| New patient visit (60+ min) | 11 | $1,461 | $133 |
| Short return visit (20+ min) | 13 | $506 | $39 |
Medicaid work
$1,466 in 2024
Medicaid paid $1,466 for 128 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 17 | $533 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 33 | $513 |
| OFF/OP EST MAY X REQ PHY/QHP | 26 | $420 |
| Service | 13 | $0 |
| Injection, diphenhydramine hcl, up to 50 mg | 13 | $0 |
| Injection, midazolam hydrochloride, per 1 mg | 13 | $0 |
| Fentanyl citrate injection | 13 | $0 |
| 2024 | 128 | 7 | 25 | $1,466 |
| 2023 | 940 | 5 | 38 | $31,699 |
| 2022 | 972 | 3 | 43 | $42,639 |
| 2021 | 1,114 | 4 | 44 | $53,480 |
| 2020 | 482 | 3 | 30 | $21,848 |
| 2019 | 183 | 2 | 26 | $8,739 |
| 2018 | 170 | 4 | 20 | $7,630 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 393 | $11,534 |
| Return visit (30+ min) | 188 | $7,481 |
| Long return visit (40+ min) | 90 | $5,297 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 140 | $4,687 |
| Telehealth originating site facility fee | 129 | $2,700 |
2022
| Long return visit (40+ min) | 339 | $21,208 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 415 | $16,294 |
| Telehealth originating site facility fee | 218 | $5,136 |
2021
| Long return visit (40+ min) | 396 | $24,436 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 525 | $23,766 |
| Telehealth originating site facility fee | 174 | $3,870 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 19 | $1,409 |
2020
| Long return visit (40+ min) | 239 | $14,173 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 136 | $5,086 |
| Telehealth originating site facility fee | 107 | $2,589 |
2019
| Long return visit (40+ min) | 86 | $4,637 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 97 | $4,102 |
2018
| Long return visit (40+ min) | 82 | $4,665 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 43 | $2,119 |
| Return visit (30+ min) | 30 | $784 |
| Injection, midazolam hydrochloride, per 1 mg | 15 | $63 |
Drugs they prescribed that Part D paid
$253,265
Pharmacies billed $253,265 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 930) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
764 generic and 166 brand-name prescriptions · $253,265 in drug cost · 42 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 77 | $120,533 | $1,565 |
| Xifaxan | 17 | $50,686 | $2,982 |
| Eliquis | 29 | $23,049 | $795 |
| Lokelma | 12 | $11,290 | $941 |
| Ursodiol | 108 | $10,321 | $96 |
See all 21 drugs
| Vemlidy | 77 | $120,533 | $1,565 |
| Xifaxan | 17 | $50,686 | $2,982 |
| Eliquis | 29 | $23,049 | $795 |
| Lokelma | 12 | $11,290 | $941 |
| Ursodiol | 108 | $10,321 | $96 |
| Mycophenolate Mofetil | 79 | $6,181 | $78 |
| Tacrolimus | 71 | $5,147 | $72 |
| Entecavir | 28 | $2,462 | $88 |
| Tenofovir Disoproxil | 14 | $2,227 | $159 |
| Lactulose | 17 | $1,190 | $70 |
| Pantoprazole | 106 | $834 | $8 |
| Omeprazole | 32 | $583 | $18 |
| Gavilyte-C | 21 | $471 | $22 |
| Levetiracetam | 11 | $246 | $22 |
| Furosemide | 24 | $109 | $5 |
| Carvedilol | 21 | $91 | $4 |
| Prednisone | 13 | $90 | $7 |
| Amlodipine Besylate | 18 | $82 | $5 |
| Tamsulosin | 20 | $78 | $4 |
| Levothyroxine | 11 | $61 | $6 |
| Trazodone | 14 | $53 | $4 |
Year by year
| 2024 | 930 | 161 | 0% (0) | 18% | $253,265 |
| 2023 | 1,329 | 170 | None | None | $526,205 |
| 2022 | 1,305 | 189 | None | None | $548,039 |
| 2021 | 1,255 | 195 | None | None | $643,636 |
| 2020 | 1,299 | 176 | None | None | $1,087,670 |
| 2019 | 1,054 | 163 | None | 24% | $739,492 |
| 2018 | 1,199 | 165 | None | 23% | $1,128,740 |
| 2017 | 958 | 166 | 2% (20) | 32% | $2,084,740 |
| 2016 | 924 | 152 | None | None | $2,918,879 |
| 2015 | 805 | 139 | 2% (12) | None | $2,571,766 |
| 2014 | 498 | 85 | 5% (25) | None | $1,326,134 |
| 2013 | 497 | 113 | 2% (11) | 36% | $240,950 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 34 drugs
| Vemlidy | 103 | $153,754 | $1,493 |
| Xifaxan | 28 | $94,870 | $3,388 |
| Viread | 15 | $29,344 | $1,956 |
| Eliquis | 35 | $23,897 | $683 |
| Ursodiol | 144 | $17,763 | $123 |
| Tacrolimus | 134 | $16,201 | $121 |
| Sirolimus | 13 | $16,146 | $1,242 |
| Mycophenolic Acid | 26 | $11,123 | $428 |
| Tenofovir Disoproxil | 27 | $10,552 | $391 |
| Entecavir | 32 | $8,338 | $261 |
| Mycophenolate Mofetil | 80 | $4,482 | $56 |
| Cyclosporine Modified | 14 | $3,934 | $281 |
| Valganciclovir | 17 | $1,647 | $97 |
| Lactulose | 28 | $1,427 | $51 |
| Azathioprine | 16 | $874 | $55 |
| Levetiracetam | 18 | $607 | $34 |
| Pantoprazole | 59 | $603 | $10 |
| Spironolactone | 29 | $541 | $19 |
| Sodium Polystyrene Sulfonate | 13 | $522 | $40 |
| Ciprofloxacin | 17 | $480 | $28 |
| Amlodipine Besylate | 28 | $417 | $15 |
| Prednisone | 23 | $398 | $17 |
| Peg 3350-Electrolyte | 17 | $380 | $22 |
| Furosemide | 45 | $362 | $8 |
| Amiloride | 26 | $268 | $10 |
| Potassium Chloride | 11 | $261 | $24 |
| Levothyroxine | 19 | $234 | $12 |
| Doxepin | 14 | $174 | $12 |
| Rosuvastatin | 11 | $124 | $11 |
| Gabapentin | 19 | $121 | $6 |
| Tamsulosin | 18 | $111 | $6 |
| Metoprolol | 17 | $94 | $6 |
| Carvedilol | 15 | $82 | $5 |
| Sulfamethoxazole-Trimethoprim | 11 | $70 | $6 |
2022: 25 drugs
| Vemlidy | 159 | $218,386 | $1,373 |
| Xifaxan | 46 | $141,643 | $3,079 |
| Viread | 12 | $25,855 | $2,155 |
| Tacrolimus | 112 | $24,268 | $217 |
| Ursodiol | 118 | $19,857 | $168 |
| Eliquis | 27 | $16,578 | $614 |
| Entecavir | 28 | $9,216 | $329 |
| Tenofovir Disoproxil | 38 | $8,807 | $232 |
| Mycophenolic Acid | 20 | $7,719 | $386 |
| Mycophenolate Mofetil | 40 | $2,671 | $67 |
| Vancomycin | 11 | $1,354 | $123 |
| Lactulose | 22 | $1,137 | $52 |
| Spironolactone | 85 | $1,027 | $12 |
| Valganciclovir | 19 | $883 | $46 |
| Peg 3350-Electrolyte | 26 | $522 | $20 |
| Pantoprazole | 53 | $497 | $9 |
| Furosemide | 85 | $455 | $5 |
| Omeprazole | 25 | $420 | $17 |
| Ciprofloxacin | 19 | $305 | $16 |
| Amlodipine Besylate | 43 | $240 | $6 |
| Amiloride | 24 | $236 | $10 |
| Prednisone | 17 | $176 | $10 |
| Tamsulosin | 22 | $94 | $4 |
| Glipizide | 13 | $87 | $7 |
| Fludrocortisone Acetate | 13 | $68 | $5 |
2021: 31 drugs
| Xifaxan | 89 | $270,098 | $3,035 |
| Vemlidy | 133 | $169,164 | $1,272 |
| Viread | 13 | $21,728 | $1,671 |
| Eliquis | 32 | $16,658 | $521 |
| Ursodiol | 111 | $16,372 | $147 |
| Mycophenolic Acid | 25 | $14,891 | $596 |
| Tacrolimus | 60 | $10,335 | $172 |
| Entecavir | 35 | $3,641 | $104 |
| Lactulose | 31 | $2,353 | $76 |
| Tenofovir Disoproxil | 36 | $1,834 | $51 |
| Mycophenolate Mofetil | 31 | $1,546 | $50 |
| Spironolactone | 67 | $1,272 | $19 |
| Generlac | 13 | $1,264 | $97 |
| Azathioprine | 24 | $1,127 | $47 |
| Ciprofloxacin | 27 | $1,057 | $39 |
| Peg 3350-Electrolyte | 39 | $609 | $16 |
| Propranolol | 21 | $596 | $28 |
| Bumetanide | 15 | $530 | $35 |
| Pantoprazole | 38 | $520 | $14 |
| Furosemide | 71 | $508 | $7 |
| Amiloride | 38 | $436 | $11 |
| Doxepin | 12 | $430 | $36 |
| Omeprazole | 27 | $370 | $14 |
| Potassium Chloride | 14 | $276 | $20 |
| Constulose | 12 | $264 | $22 |
| Amlodipine Besylate | 25 | $195 | $8 |
| Carvedilol | 17 | $152 | $9 |
| Prednisone | 12 | $112 | $9 |
| Famotidine | 11 | $56 | $5 |
| Sulfamethoxazole-Trimethoprim | 20 | $43 | $2 |
| Glipizide | 13 | $37 | $3 |
2020: 31 drugs
| Vemlidy | 154 | $186,105 | $1,208 |
| Xifaxan | 67 | $175,008 | $2,612 |
| Mycophenolic Acid | 48 | $24,042 | $501 |
| Viread | 13 | $18,507 | $1,424 |
| Tacrolimus | 100 | $15,332 | $153 |
| Ursodiol | 81 | $14,387 | $178 |
| Eliquis | 25 | $12,297 | $492 |
| Atovaquone | 11 | $9,905 | $900 |
| Tenofovir Disoproxil | 51 | $3,558 | $70 |
| Entecavir | 31 | $2,740 | $88 |
| Mycophenolate Mofetil | 24 | $2,400 | $100 |
| Lactulose | 21 | $1,541 | $73 |
| Azathioprine | 26 | $1,241 | $48 |
| Pantoprazole | 56 | $761 | $14 |
| Generlac | 16 | $706 | $44 |
| Spironolactone | 41 | $590 | $14 |
| Propranolol | 14 | $587 | $42 |
| Amiloride | 28 | $577 | $21 |
| Furosemide | 64 | $477 | $7 |
| Ondansetron Odt | 12 | $371 | $31 |
| Constulose | 15 | $330 | $22 |
| Ciprofloxacin | 13 | $298 | $23 |
| Gabapentin | 13 | $232 | $18 |
| Gavilyte-G | 16 | $211 | $13 |
| Prednisone | 16 | $188 | $12 |
| Amlodipine Besylate | 42 | $185 | $4 |
| Omeprazole | 18 | $149 | $8 |
| Bumetanide | 12 | $149 | $12 |
| Gavilyte-C | 11 | $143 | $13 |
| Carvedilol | 15 | $96 | $6 |
| Glipizide | 14 | $38 | $3 |
2019: 32 drugs
| Mavyret | 11 | $150,092 | $13,645 |
| Vemlidy | 78 | $88,339 | $1,133 |
| Xifaxan | 29 | $71,755 | $2,474 |
| Nexavar | 11 | $54,674 | $4,970 |
| Viread | 16 | $29,971 | $1,873 |
| Mycophenolic Acid | 31 | $16,428 | $530 |
| Tenofovir Disoproxil | 47 | $9,709 | $207 |
| Tacrolimus | 73 | $9,388 | $129 |
| Ursodiol | 33 | $7,484 | $227 |
| Entecavir | 26 | $6,683 | $257 |
| Mycophenolate Mofetil | 35 | $4,941 | $141 |
| Envarsus Xr | 11 | $3,585 | $326 |
| Potassium Chloride | 11 | $1,161 | $106 |
| Pantoprazole | 63 | $1,147 | $18 |
| Azathioprine | 16 | $938 | $59 |
| Propranolol | 29 | $804 | $28 |
| Lactulose | 16 | $762 | $48 |
| Spironolactone | 34 | $659 | $19 |
| Ondansetron Odt | 17 | $521 | $31 |
| Amlodipine Besylate | 60 | $374 | $6 |
| Furosemide | 50 | $334 | $7 |
| Ciprofloxacin | 14 | $282 | $20 |
| Tamsulosin | 18 | $282 | $16 |
| Gavilyte-G | 19 | $267 | $14 |
| Peg 3350-Electrolyte | 13 | $219 | $17 |
| Prednisone | 12 | $203 | $17 |
| Gabapentin | 12 | $179 | $15 |
| Omeprazole | 14 | $157 | $11 |
| Amiloride | 11 | $117 | $11 |
| Carvedilol | 13 | $95 | $7 |
| Metoprolol | 18 | $62 | $3 |
| Glipizide | 14 | $41 | $3 |
2018: 31 drugs
| Mavyret | 12 | $162,270 | $13,522 |
| Xifaxan | 41 | $90,090 | $2,197 |
| Vemlidy | 60 | $65,400 | $1,090 |
| Viread | 29 | $34,384 | $1,186 |
| Valganciclovir | 14 | $20,198 | $1,443 |
| Entecavir | 25 | $19,730 | $789 |
| Tenofovir Disoproxil | 43 | $15,984 | $372 |
| Ursodiol | 43 | $14,113 | $328 |
| Atovaquone | 11 | $12,194 | $1,109 |
| Mycophenolate Mofetil | 54 | $9,645 | $179 |
| Tacrolimus | 68 | $9,251 | $136 |
| Mycophenolic Acid | 15 | $5,353 | $357 |
| Sirolimus | 13 | $4,657 | $358 |
| Azathioprine | 26 | $1,653 | $64 |
| Spironolactone | 44 | $1,085 | $25 |
| Lactulose | 31 | $1,042 | $34 |
| Omeprazole | 86 | $708 | $8 |
| Generlac | 21 | $666 | $32 |
| Propranolol | 31 | $517 | $17 |
| Amlodipine Besylate | 63 | $364 | $6 |
| Levothyroxine | 17 | $347 | $20 |
| Ondansetron | 15 | $307 | $20 |
| Polyethylene Glycol 3350 | 12 | $293 | $24 |
| Fludrocortisone Acetate | 18 | $282 | $16 |
| Pantoprazole | 37 | $266 | $7 |
| Peg 3350-Electrolyte | 17 | $262 | $15 |
| Furosemide | 59 | $228 | $4 |
| Tamsulosin | 13 | $165 | $13 |
| Metoprolol | 34 | $111 | $3 |
| Glipizide | 16 | $74 | $5 |
| Sulfamethoxazole-Trimethoprim | 11 | $70 | $6 |
2017: 25 drugs
| Epclusa | 37 | $950,871 | $25,699 |
| Harvoni | 18 | $585,558 | $32,531 |
| Xifaxan | 44 | $97,195 | $2,209 |
| Viread | 59 | $62,553 | $1,060 |
| Vemlidy | 38 | $38,388 | $1,010 |
| Ursodiol | 28 | $11,746 | $420 |
| Valganciclovir | 11 | $11,497 | $1,045 |
| Tacrolimus | 34 | $5,543 | $163 |
| Mycophenolate Mofetil | 37 | $2,120 | $57 |
| Cyclosporine Modified | 11 | $1,601 | $146 |
| Lactulose | 39 | $1,380 | $35 |
| Azathioprine | 18 | $1,283 | $71 |
| Ribasphere | 11 | $933 | $85 |
| Cholestyramine | 12 | $908 | $76 |
| Spironolactone | 33 | $495 | $15 |
| Polyethylene Glycol 3350 | 16 | $427 | $27 |
| Omeprazole | 50 | $389 | $8 |
| Peg 3350-Electrolyte | 22 | $361 | $16 |
| Propranolol | 16 | $331 | $21 |
| Gabapentin | 11 | $314 | $29 |
| Amlodipine Besylate | 37 | $211 | $6 |
| Furosemide | 42 | $153 | $4 |
| Pantoprazole | 23 | $143 | $6 |
| Prednisone | 17 | $117 | $7 |
| Quetiapine | 11 | $57 | $5 |
2016: 27 drugs
| Harvoni | 47 | $1,488,102 | $31,662 |
| Sovaldi | 21 | $578,998 | $27,571 |
| Daklinza | 16 | $330,361 | $20,648 |
| Epclusa | 11 | $274,974 | $24,998 |
| Viread | 50 | $49,441 | $989 |
| Xifaxan | 24 | $46,033 | $1,918 |
| Ursodiol | 49 | $14,292 | $292 |
| Tacrolimus | 42 | $4,963 | $118 |
| Prograf | 13 | $3,914 | $301 |
| Ribasphere | 22 | $2,630 | $120 |
| Mycophenolate Mofetil | 47 | $1,850 | $39 |
| Cyclosporine Modified | 13 | $1,542 | $119 |
| Propranolol | 35 | $1,041 | $30 |
| Spironolactone | 48 | $668 | $14 |
| Levothyroxine | 27 | $360 | $13 |
| Gabapentin | 18 | $352 | $20 |
| Generlac | 13 | $316 | $24 |
| Lactulose | 15 | $310 | $21 |
| Omeprazole | 39 | $306 | $8 |
| Furosemide | 59 | $201 | $3 |
| Peg 3350-Electrolyte | 12 | $201 | $17 |
| Pantoprazole | 24 | $194 | $8 |
| Metoprolol | 12 | $176 | $15 |
| Glimepiride | 13 | $127 | $10 |
| Amlodipine Besylate | 29 | $97 | $3 |
| Promethazine | 12 | $66 | $6 |
| Sulfamethoxazole-Trimethoprim | 13 | $51 | $4 |
2015: 23 drugs
| Harvoni | 54 | $1,705,475 | $31,583 |
| Sovaldi | 17 | $468,804 | $27,577 |
| Nexavar | 15 | $132,163 | $8,811 |
| Xifaxan | 27 | $41,837 | $1,550 |
| Viread | 32 | $30,011 | $938 |
| Tacrolimus | 60 | $9,853 | $164 |
| Ursodiol | 28 | $6,657 | $238 |
| Prograf | 13 | $3,742 | $288 |
| Ribasphere | 17 | $1,927 | $113 |
| Nadolol | 14 | $1,085 | $78 |
| Spironolactone | 52 | $987 | $19 |
| Lactulose | 17 | $695 | $41 |
| Mycophenolate Mofetil | 14 | $482 | $34 |
| Propranolol | 29 | $438 | $15 |
| Amiloride | 17 | $407 | $24 |
| Generlac | 12 | $312 | $26 |
| Omeprazole | 35 | $256 | $7 |
| Furosemide | 62 | $222 | $4 |
| Pantoprazole | 13 | $141 | $11 |
| Amlodipine Besylate | 18 | $115 | $6 |
| Sertraline | 11 | $44 | $4 |
| Metoprolol | 11 | $44 | $4 |
| Lisinopril | 11 | $34 | $3 |
2014: 14 drugs
| Sovaldi | 24 | $691,469 | $28,811 |
| Olysio | 18 | $406,550 | $22,586 |
| Xifaxan | 32 | $41,697 | $1,303 |
| Viread | 25 | $22,235 | $889 |
| Baraclude | 11 | $13,305 | $1,210 |
| Tacrolimus | 25 | $5,133 | $205 |
| Neoral | 12 | $2,118 | $177 |
| Ursodiol | 17 | $1,375 | $81 |
| Spironolactone | 25 | $541 | $22 |
| Lactulose | 18 | $330 | $18 |
| Furosemide | 41 | $157 | $4 |
| Propranolol | 20 | $138 | $7 |
| Hydroxyzine | 11 | $95 | $9 |
| Omeprazole | 13 | $91 | $7 |
2013: 13 drugs
| Xifaxan | 73 | $95,109 | $1,303 |
| Pegasys | 18 | $49,542 | $2,752 |
| Ribavirin | 17 | $4,019 | $236 |
| Tacrolimus | 17 | $3,080 | $181 |
| Spironolactone | 53 | $2,121 | $40 |
| Lactulose | 18 | $1,223 | $68 |
| Ursodiol | 11 | $990 | $90 |
| Amiloride | 14 | $834 | $60 |
| Polyethylene Glycol 3350 | 13 | $310 | $24 |
| Propranolol | 36 | $234 | $6 |
| Furosemide | 51 | $221 | $4 |
| Omeprazole | 14 | $203 | $14 |
| Ciprofloxacin | 12 | $112 | $9 |
Money from drug and device companies
$97 in 2025
| 2025 | 1 | 1 | None | $97 |
| 2024 | 1 | 1 | None | $15 |
| 2020 | 1 | 1 | None | $29 |
| 2019 | 1 | 1 | None | $21 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Cook Medical | Echotip Insight | $97 | 1 payment
|
See the published payment
| Cook Medical | Meals · 2025-09-16 | Echotip Insight | $97 |
See earlier years (2024, 2020, 2019)
2024: $15
| Bayer Healthcare Pharmaceuticals | Xofigo | $15 | 1 payment
|
2020: $29
| Gilead Sciences | None | $29 | 1 payment
|
2019: $21
| Intercept Pharmaceuticals | Ocaliva | $21 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Mallinckrodt Enterprises LLC · A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study To Confirm Efficacy and Safety of Terlipressin in Subjects With Hepatorenal Syndrome Type 1 · 2019 | Their institution | $5,321 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1275738445
- Licence
- CA A117307, MO 2006018042California A117307: Current · expires 2027-02-28
- Group
- Central California Faculty Medical Group Inc · Central Valley General Hospital · Adventist Health Physicians Network · Alameda Health System · Permanente Medical Group Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Federal specialty code 207RI0008X (207RI0008X); Federal specialty code 207RT0003X (207RT0003X)
- Mailing address
- 2625 E Divisadero St, Fresno, CA, 93721
- NPI first listed
- 2007-06-18
- NPI last updated
- 2026-08-07
- NPI record certified
- 2026-08-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2823 Fresno St, Fresno, CA, 93721 · 750 Welch Rd, Palo Alto, CA, 94304 · 2 James Way Ste 207, Pismo Beach, CA, 93449 · 1551 Bishop St Ste 230, San Luis Obispo, CA, 93401 · 1551 Bishop St Ste 510, San Luis Obispo, CA, 93401 · 1255 Las Tablas Rd Ste 201, Templeton, CA, 93465